AKERO THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.65 USD | -5.53% |
|
-0.05% | -15.85% |
| 10/05 | Akero Therapeutics' Q1 Net Loss Widens; Cash Expected to Fund Operations Into H2 2027 | MT |
| 30/04 | Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer | CI |